FDA Clears AI Tool for Coronary Plaque Analysis
The clearance enables on-premise AI analysis of coronary CT angiography for quantifying calcified and non-calcified plaque.
The clearance enables on-premise AI analysis of coronary CT angiography for quantifying calcified and non-calcified plaque.
The clearance enables on-premise AI analysis of coronary CT angiography for quantifying calcified and non-calcified plaque.